Structure

Physi-Chem Properties

Molecular Weight:  712.43
Volume:  764.784
LogP:  8.182
LogD:  6.154
LogS:  -4.608
# Rotatable Bonds:  8
TPSA:  102.29
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  7
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.227
Synthetic Accessibility Score:  5.234
Fsp3:  0.644
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.2
MDCK Permeability:  2.012512595683802e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.011
30% Bioavailability (F30%):  0.252

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.003
Plasma Protein Binding (PPB):  101.6043930053711%
Volume Distribution (VD):  0.959
Pgp-substrate:  5.509104251861572%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.441
CYP2C19-inhibitor:  0.149
CYP2C19-substrate:  0.795
CYP2C9-inhibitor:  0.119
CYP2C9-substrate:  0.957
CYP2D6-inhibitor:  0.105
CYP2D6-substrate:  0.77
CYP3A4-inhibitor:  0.422
CYP3A4-substrate:  0.582

ADMET: Excretion

Clearance (CL):  7.509
Half-life (T1/2):  0.203

ADMET: Toxicity

hERG Blockers:  0.55
Human Hepatotoxicity (H-HT):  0.144
Drug-inuced Liver Injury (DILI):  0.038
AMES Toxicity:  0.002
Rat Oral Acute Toxicity:  0.174
Maximum Recommended Daily Dose:  0.903
Skin Sensitization:  0.381
Carcinogencity:  0.008
Eye Corrosion:  0.004
Eye Irritation:  0.215
Respiratory Toxicity:  0.485

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC177362

Natural Product ID:  NPC177362
Common Name*:   Ulmicin E
IUPAC Name:   [(1R,3aR,5S,5aR,5bR,7aR,9S,11aS,11bR,12R,13aR,13bR)-5-benzoyloxy-9-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-12-yl] 4-hydroxy-3-methoxybenzoate
Synonyms:   ulmicin E
Standard InCHIKey:  BXULOPKZYSOQMM-RWUMXVMBSA-N
Standard InCHI:  InChI=1S/C45H60O7/c1-26(2)29-17-20-42(5)25-36(52-39(48)27-13-11-10-12-14-27)45(8)30(37(29)42)24-33(51-40(49)28-15-16-31(46)32(23-28)50-9)38-43(6)21-19-35(47)41(3,4)34(43)18-22-44(38,45)7/h10-16,23,29-30,33-38,46-47H,1,17-22,24-25H2,2-9H3/t29-,30+,33+,34-,35-,36-,37+,38+,42+,43-,44+,45-/m0/s1
SMILES:  COc1cc(ccc1O)C(=O)O[C@@H]1C[C@@H]2[C@H]3[C@@H](CC[C@]3(C)C[C@@H]([C@]2([C@]2([C@H]1[C@@]1(C)CC[C@@H](C([C@@H]1CC2)(C)C)O)C)C)OC(=O)c1ccccc1)C(=C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL500710
PubChem CID:   21590546
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2200.1 Ulmus davidiana Under-species n.a. n.a. n.a. n.a. n.a. PMID[11277749]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 41.0 % PMID[534731]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC177362 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9937 High Similarity NPC266545
0.9937 High Similarity NPC202428
0.9936 High Similarity NPC200726
0.9268 High Similarity NPC472803
0.9236 High Similarity NPC105942
0.9236 High Similarity NPC205392
0.9057 High Similarity NPC62051
0.8987 High Similarity NPC118033
0.8981 High Similarity NPC279442
0.8931 High Similarity NPC475579
0.8931 High Similarity NPC124842
0.8931 High Similarity NPC473773
0.8868 High Similarity NPC475311
0.8868 High Similarity NPC473579
0.8868 High Similarity NPC473680
0.8868 High Similarity NPC475454
0.8848 High Similarity NPC100420
0.8841 High Similarity NPC266365
0.8805 High Similarity NPC470619
0.8805 High Similarity NPC208785
0.8805 High Similarity NPC470618
0.8805 High Similarity NPC145527
0.8805 High Similarity NPC327962
0.879 High Similarity NPC66894
0.879 High Similarity NPC8102
0.8742 High Similarity NPC273358
0.8742 High Similarity NPC298647
0.8735 High Similarity NPC45943
0.8728 High Similarity NPC473205
0.8728 High Similarity NPC473776
0.8726 High Similarity NPC235195
0.8726 High Similarity NPC469683
0.8726 High Similarity NPC19862
0.8696 High Similarity NPC267091
0.8688 High Similarity NPC142654
0.8679 High Similarity NPC32017
0.8679 High Similarity NPC96930
0.8662 High Similarity NPC469615
0.8639 High Similarity NPC21956
0.8634 High Similarity NPC243891
0.8625 High Similarity NPC292206
0.8614 High Similarity NPC216916
0.8608 High Similarity NPC271607
0.8608 High Similarity NPC280717
0.8608 High Similarity NPC307205
0.8599 High Similarity NPC252133
0.8596 High Similarity NPC316539
0.8596 High Similarity NPC475299
0.8589 High Similarity NPC469888
0.8588 High Similarity NPC180768
0.8563 High Similarity NPC188217
0.8562 High Similarity NPC325032
0.8562 High Similarity NPC477483
0.8553 High Similarity NPC75295
0.8545 High Similarity NPC296044
0.8545 High Similarity NPC167098
0.8538 High Similarity NPC100925
0.8538 High Similarity NPC469773
0.8538 High Similarity NPC469775
0.8538 High Similarity NPC32723
0.8538 High Similarity NPC469772
0.8538 High Similarity NPC469778
0.8538 High Similarity NPC295941
0.8538 High Similarity NPC135334
0.8538 High Similarity NPC469776
0.8538 High Similarity NPC469777
0.8538 High Similarity NPC469774
0.8537 High Similarity NPC472807
0.8535 High Similarity NPC35212
0.8523 High Similarity NPC299855
0.8523 High Similarity NPC96194
0.8521 High Similarity NPC263212
0.8509 High Similarity NPC98809
0.8509 High Similarity NPC476394
0.8503 High Similarity NPC469889
0.8503 High Similarity NPC131905
0.8491 Intermediate Similarity NPC53520
0.8488 Intermediate Similarity NPC98583
0.8481 Intermediate Similarity NPC469447
0.8481 Intermediate Similarity NPC477873
0.8481 Intermediate Similarity NPC310621
0.8475 Intermediate Similarity NPC189704
0.8471 Intermediate Similarity NPC473612
0.8471 Intermediate Similarity NPC286809
0.8466 Intermediate Similarity NPC48671
0.8457 Intermediate Similarity NPC303989
0.8457 Intermediate Similarity NPC474305
0.8452 Intermediate Similarity NPC476371
0.8452 Intermediate Similarity NPC145847
0.8452 Intermediate Similarity NPC476372
0.8447 Intermediate Similarity NPC472969
0.8447 Intermediate Similarity NPC470757
0.8444 Intermediate Similarity NPC476358
0.8443 Intermediate Similarity NPC476373
0.8443 Intermediate Similarity NPC24627
0.8439 Intermediate Similarity NPC469438
0.8439 Intermediate Similarity NPC469354
0.8438 Intermediate Similarity NPC258856
0.8434 Intermediate Similarity NPC143328
0.843 Intermediate Similarity NPC65333
0.843 Intermediate Similarity NPC100251
0.8428 Intermediate Similarity NPC26045
0.8428 Intermediate Similarity NPC473090
0.8428 Intermediate Similarity NPC25491
0.8427 Intermediate Similarity NPC475121
0.8427 Intermediate Similarity NPC476067
0.8424 Intermediate Similarity NPC180901
0.8424 Intermediate Similarity NPC300757
0.8415 Intermediate Similarity NPC131121
0.8405 Intermediate Similarity NPC261659
0.8402 Intermediate Similarity NPC161151
0.8402 Intermediate Similarity NPC277618
0.8402 Intermediate Similarity NPC100425
0.8402 Intermediate Similarity NPC109990
0.84 Intermediate Similarity NPC93685
0.84 Intermediate Similarity NPC108191
0.8395 Intermediate Similarity NPC474306
0.8395 Intermediate Similarity NPC475848
0.8391 Intermediate Similarity NPC469397
0.8385 Intermediate Similarity NPC58752
0.8373 Intermediate Similarity NPC470896
0.8373 Intermediate Similarity NPC7059
0.8373 Intermediate Similarity NPC473275
0.8365 Intermediate Similarity NPC141817
0.8365 Intermediate Similarity NPC176030
0.8365 Intermediate Similarity NPC229218
0.8365 Intermediate Similarity NPC192597
0.8365 Intermediate Similarity NPC169214
0.8365 Intermediate Similarity NPC235557
0.8354 Intermediate Similarity NPC27518
0.8354 Intermediate Similarity NPC304110
0.8353 Intermediate Similarity NPC310572
0.8344 Intermediate Similarity NPC248287
0.8344 Intermediate Similarity NPC261322
0.8344 Intermediate Similarity NPC234548
0.8343 Intermediate Similarity NPC473445
0.8333 Intermediate Similarity NPC185617
0.8333 Intermediate Similarity NPC53889
0.8333 Intermediate Similarity NPC79571
0.8324 Intermediate Similarity NPC148185
0.8323 Intermediate Similarity NPC226759
0.8323 Intermediate Similarity NPC187205
0.8314 Intermediate Similarity NPC186100
0.8314 Intermediate Similarity NPC216403
0.8314 Intermediate Similarity NPC41494
0.8313 Intermediate Similarity NPC46161
0.8313 Intermediate Similarity NPC471876
0.8313 Intermediate Similarity NPC239608
0.8304 Intermediate Similarity NPC43065
0.8304 Intermediate Similarity NPC296558
0.8303 Intermediate Similarity NPC65591
0.8303 Intermediate Similarity NPC295646
0.8303 Intermediate Similarity NPC178574
0.8294 Intermediate Similarity NPC223006
0.8294 Intermediate Similarity NPC272750
0.8294 Intermediate Similarity NPC291977
0.8294 Intermediate Similarity NPC173729
0.8294 Intermediate Similarity NPC134047
0.8293 Intermediate Similarity NPC119252
0.8286 Intermediate Similarity NPC478050
0.8286 Intermediate Similarity NPC79736
0.8286 Intermediate Similarity NPC475054
0.8286 Intermediate Similarity NPC67629
0.8286 Intermediate Similarity NPC472723
0.8278 Intermediate Similarity NPC71385
0.8278 Intermediate Similarity NPC230670
0.8276 Intermediate Similarity NPC195972
0.8276 Intermediate Similarity NPC475197
0.8276 Intermediate Similarity NPC473467
0.8274 Intermediate Similarity NPC8389
0.8274 Intermediate Similarity NPC471750
0.8274 Intermediate Similarity NPC68619
0.8274 Intermediate Similarity NPC179914
0.8274 Intermediate Similarity NPC87317
0.8272 Intermediate Similarity NPC191899
0.8272 Intermediate Similarity NPC246229
0.8272 Intermediate Similarity NPC474991
0.8266 Intermediate Similarity NPC476365
0.8263 Intermediate Similarity NPC478223
0.8263 Intermediate Similarity NPC471968
0.8263 Intermediate Similarity NPC213401
0.8253 Intermediate Similarity NPC305710
0.8253 Intermediate Similarity NPC25127
0.8246 Intermediate Similarity NPC471788
0.8242 Intermediate Similarity NPC75695
0.8242 Intermediate Similarity NPC270268
0.8242 Intermediate Similarity NPC294511
0.8242 Intermediate Similarity NPC121615
0.8242 Intermediate Similarity NPC476434
0.8239 Intermediate Similarity NPC470035
0.8239 Intermediate Similarity NPC469418
0.8239 Intermediate Similarity NPC267549
0.8239 Intermediate Similarity NPC29599
0.8239 Intermediate Similarity NPC172311
0.8239 Intermediate Similarity NPC100675
0.8239 Intermediate Similarity NPC260300
0.8239 Intermediate Similarity NPC326065
0.8235 Intermediate Similarity NPC144557
0.8235 Intermediate Similarity NPC476011
0.8235 Intermediate Similarity NPC149389

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC177362 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8614 High Similarity NPD8127 Discontinued
0.84 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8382 Intermediate Similarity NPD7685 Pre-registration
0.8362 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD8166 Discontinued
0.8187 Intermediate Similarity NPD4628 Phase 3
0.816 Intermediate Similarity NPD6273 Approved
0.8155 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD7458 Discontinued
0.8103 Intermediate Similarity NPD5844 Phase 1
0.8046 Intermediate Similarity NPD7228 Approved
0.8011 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD7473 Discontinued
0.7953 Intermediate Similarity NPD6234 Discontinued
0.7919 Intermediate Similarity NPD6232 Discontinued
0.7877 Intermediate Similarity NPD8313 Approved
0.7877 Intermediate Similarity NPD8312 Approved
0.787 Intermediate Similarity NPD37 Approved
0.7853 Intermediate Similarity NPD7003 Approved
0.7836 Intermediate Similarity NPD4965 Approved
0.7836 Intermediate Similarity NPD4967 Phase 2
0.7836 Intermediate Similarity NPD4966 Approved
0.7829 Intermediate Similarity NPD6166 Phase 2
0.7829 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7772 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD1934 Approved
0.7759 Intermediate Similarity NPD7199 Phase 2
0.7753 Intermediate Similarity NPD7074 Phase 3
0.7747 Intermediate Similarity NPD8434 Phase 2
0.774 Intermediate Similarity NPD3818 Discontinued
0.7719 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD1465 Phase 2
0.7697 Intermediate Similarity NPD6190 Approved
0.7697 Intermediate Similarity NPD7054 Approved
0.7654 Intermediate Similarity NPD7472 Approved
0.763 Intermediate Similarity NPD3882 Suspended
0.7625 Intermediate Similarity NPD3620 Phase 2
0.7625 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD2801 Approved
0.76 Intermediate Similarity NPD5494 Approved
0.7576 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD7240 Approved
0.7554 Intermediate Similarity NPD8150 Discontinued
0.7552 Intermediate Similarity NPD7497 Discontinued
0.7544 Intermediate Similarity NPD4380 Phase 2
0.753 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD4110 Phase 3
0.7527 Intermediate Similarity NPD7808 Phase 3
0.7527 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD5761 Phase 2
0.7514 Intermediate Similarity NPD7819 Suspended
0.7514 Intermediate Similarity NPD5760 Phase 2
0.7486 Intermediate Similarity NPD7075 Discontinued
0.7473 Intermediate Similarity NPD7251 Discontinued
0.7471 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD3817 Phase 2
0.7469 Intermediate Similarity NPD230 Phase 1
0.7442 Intermediate Similarity NPD7028 Phase 2
0.744 Intermediate Similarity NPD7236 Approved
0.7429 Intermediate Similarity NPD7768 Phase 2
0.7421 Intermediate Similarity NPD9494 Approved
0.7418 Intermediate Similarity NPD6797 Phase 2
0.7414 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD8455 Phase 2
0.7399 Intermediate Similarity NPD6386 Approved
0.7399 Intermediate Similarity NPD6385 Approved
0.7391 Intermediate Similarity NPD3764 Approved
0.7384 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD3226 Approved
0.7371 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD6355 Discontinued
0.736 Intermediate Similarity NPD8151 Discontinued
0.736 Intermediate Similarity NPD6959 Discontinued
0.7353 Intermediate Similarity NPD2533 Approved
0.7353 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD2534 Approved
0.7353 Intermediate Similarity NPD2532 Approved
0.7349 Intermediate Similarity NPD5762 Approved
0.7349 Intermediate Similarity NPD5763 Approved
0.7349 Intermediate Similarity NPD7266 Discontinued
0.7346 Intermediate Similarity NPD6663 Approved
0.7346 Intermediate Similarity NPD8032 Phase 2
0.7341 Intermediate Similarity NPD6599 Discontinued
0.7333 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD5736 Approved
0.7308 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD4140 Approved
0.7294 Intermediate Similarity NPD1511 Approved
0.7289 Intermediate Similarity NPD2935 Discontinued
0.7288 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD6764 Approved
0.7283 Intermediate Similarity NPD6765 Approved
0.7282 Intermediate Similarity NPD7435 Discontinued
0.7282 Intermediate Similarity NPD7680 Approved
0.7257 Intermediate Similarity NPD6801 Discontinued
0.7254 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7239 Suspended
0.7222 Intermediate Similarity NPD3027 Phase 3
0.7219 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD3750 Approved
0.7209 Intermediate Similarity NPD1512 Approved
0.7202 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7411 Suspended
0.7189 Intermediate Similarity NPD7038 Approved
0.7189 Intermediate Similarity NPD7039 Approved
0.7189 Intermediate Similarity NPD6559 Discontinued
0.7175 Intermediate Similarity NPD5402 Approved
0.717 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD7097 Phase 1
0.7166 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7799 Discontinued
0.7158 Intermediate Similarity NPD7177 Discontinued
0.7157 Intermediate Similarity NPD7870 Phase 2
0.7157 Intermediate Similarity NPD7871 Phase 2
0.7152 Intermediate Similarity NPD5735 Approved
0.715 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7874 Approved
0.7143 Intermediate Similarity NPD2346 Discontinued
0.7128 Intermediate Similarity NPD6778 Approved
0.7128 Intermediate Similarity NPD6777 Approved
0.7128 Intermediate Similarity NPD6779 Approved
0.7128 Intermediate Similarity NPD6785 Approved
0.7128 Intermediate Similarity NPD6784 Approved
0.7128 Intermediate Similarity NPD6780 Approved
0.7128 Intermediate Similarity NPD6776 Approved
0.7128 Intermediate Similarity NPD6782 Approved
0.7128 Intermediate Similarity NPD6781 Approved
0.7126 Intermediate Similarity NPD2799 Discontinued
0.7117 Intermediate Similarity NPD7095 Approved
0.7107 Intermediate Similarity NPD7696 Phase 3
0.7107 Intermediate Similarity NPD1608 Approved
0.7107 Intermediate Similarity NPD7697 Approved
0.7107 Intermediate Similarity NPD7698 Approved
0.7102 Intermediate Similarity NPD6873 Phase 2
0.7095 Intermediate Similarity NPD3749 Approved
0.7093 Intermediate Similarity NPD6799 Approved
0.7091 Intermediate Similarity NPD4060 Phase 1
0.7088 Intermediate Similarity NPD5242 Approved
0.7079 Intermediate Similarity NPD5978 Approved
0.7079 Intermediate Similarity NPD5977 Approved
0.7079 Intermediate Similarity NPD5353 Approved
0.7073 Intermediate Similarity NPD6798 Discontinued
0.7071 Intermediate Similarity NPD8320 Phase 1
0.7071 Intermediate Similarity NPD8319 Approved
0.7065 Intermediate Similarity NPD3751 Discontinued
0.7059 Intermediate Similarity NPD6674 Discontinued
0.7052 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD7701 Phase 2
0.7048 Intermediate Similarity NPD447 Suspended
0.7033 Intermediate Similarity NPD7229 Phase 3
0.7033 Intermediate Similarity NPD3787 Discontinued
0.703 Intermediate Similarity NPD7783 Phase 2
0.703 Intermediate Similarity NPD7801 Approved
0.703 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD7033 Discontinued
0.7024 Intermediate Similarity NPD1510 Phase 2
0.7019 Intermediate Similarity NPD1283 Approved
0.7019 Intermediate Similarity NPD1876 Approved
0.7012 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6653 Approved
0.7006 Intermediate Similarity NPD9545 Approved
0.7 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7831 Phase 2
0.7 Intermediate Similarity NPD7833 Phase 2
0.7 Intermediate Similarity NPD3972 Approved
0.7 Intermediate Similarity NPD1549 Phase 2
0.6994 Remote Similarity NPD2861 Phase 2
0.6989 Remote Similarity NPD3455 Phase 2
0.6988 Remote Similarity NPD2979 Phase 3
0.6988 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6988 Remote Similarity NPD1613 Approved
0.6982 Remote Similarity NPD2438 Suspended
0.6982 Remote Similarity NPD5404 Approved
0.6982 Remote Similarity NPD5405 Approved
0.6982 Remote Similarity NPD5406 Approved
0.6982 Remote Similarity NPD6099 Approved
0.6982 Remote Similarity NPD6100 Approved
0.6982 Remote Similarity NPD5408 Approved
0.6979 Remote Similarity NPD2488 Approved
0.6979 Remote Similarity NPD2490 Approved
0.6971 Remote Similarity NPD5403 Approved
0.697 Remote Similarity NPD6859 Clinical (unspecified phase)
0.697 Remote Similarity NPD6823 Phase 2
0.6961 Remote Similarity NPD919 Approved
0.6954 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6941 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6941 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6941 Remote Similarity NPD6005 Phase 3
0.6941 Remote Similarity NPD6004 Phase 3
0.6941 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6941 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6941 Remote Similarity NPD6002 Phase 3
0.6941 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6939 Remote Similarity NPD7700 Phase 2
0.6939 Remote Similarity NPD7699 Phase 2
0.6932 Remote Similarity NPD1653 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data